|Bid||40.96 x 800|
|Ask||164.19 x 900|
|Day's Range||98.70 - 103.01|
|52 Week Range||73.66 - 114.99|
|Beta (5Y Monthly)||0.83|
|PE Ratio (TTM)||49.26|
|Earnings Date||May 01, 2023 - May 05, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||125.13|
Here is how Addus HomeCare (ADUS) and Amphastar Pharmaceuticals (AMPH) have performed compared to their sector so far this year.
Chemed, Addus HomeCare, RadNet and The Pennant Group are part of the Zacks Industry Outlook article.
Despite the macroeconomic challenges, rising dependence on telehealth and the dominance of AI are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. CHE, ADUS, RDNT and PNTG are well poised to gain from the prospects.